Discover investment opportunities in Canadian Weed Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Canadian Weed Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Canadian Weed Stocks using our Smart AI Filter.
5 stocks found for "Canadian Weed Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.86 | ±55.0% | 41.8 | 0.00% | |||
1.42 | ±65.6% | -42.3 | 0.00% | |||
1.41 | ±67.6% | -20.4 | 0.00% | |||
1.43 | ±73.1% | -7.7 | 0.00% | |||
1.99 | ±100.0% | -1.7 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What are the growth prospects for Canadian cannabis stocks like CGC and TLRY?
A: The Canadian cannabis market benefits from federal legalization, with companies like CGC and TLRY expanding into international markets. Growth prospects can be impacted by regulatory changes, market saturation, and competition. Historically, these stocks have shown high volatility. Investors should consider market trends and company strategies for a comprehensive evaluation.
Q: How have Canadian cannabis stocks such as ACB performed during economic downturns?
A: Historically, Canadian cannabis stocks like ACB have demonstrated significant volatility during economic downturns due to their high-risk nature. Overproduction and fluctuating demand compounded these effects, leading to sharp price movements. Investors should analyze historical performance for insights on future resilience.
Q: What dividends do Canadian cannabis companies like APHA typically offer?
A: Canadian cannabis companies, including APHA, traditionally focus on growth and reinvestment, often not providing regular dividends. Investors looking for income may need to consider other sectors. It's advisable to verify current financials for any changes in dividend policies.
Q: What are the main risks associated with investing in companies like CRON and HEXO?
A: Risks for investing in companies like CRON and HEXO include regulatory constraints, market saturation, and potential oversupply. Additionally, competition and financial stability are important factors. Legal developments and industry consolidation may also impact these stocks' performances.
Q: Can cannabis stocks such as VFF provide stability in a diversified portfolio?
A: Cannabis stocks like VFF often exhibit high volatility, typically contributing to portfolio risk rather than stability. However, they may offer growth potential. Investors seeking diversification should balance cannabis holdings with more stable sectors to offset potential volatility.
Q: Are Canadian cannabis stocks like GRWG involved in sustainable practices?
A: Sustainability practices vary among Canadian cannabis companies. GRWG focuses on providing technology and equipment for efficient cannabis cultivation, which may align with sustainable operations. Interested investors should investigate specific sustainability initiatives and ESG factors of individual stocks.
Cannabis grower Organigram Holdings Inc. OGI reported third-quarter 2025 net sales of $51.14 million, approximately $70.8 million Canadian dollars (CAD), up 72% year-over-year, beating the consensus of $48.33 million.
Read moreCannabis stocks are rising after President Joe Biden publicly endorsed the Justice Department's recommendation to loosen restrictions on marijuana, reclassified from a Schedule I to a Schedule III drug. Poseidon Investment Management co-founder Emily Paxhia joins Market Domination to break down the news.
Read more